Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy
Liang Huang(Fudan University Shanghai Cancer Center), Zhi‐Ming Shao(Shanghai Medical College of Fudan University)
Cited by 8
Related Papers
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
|Blood|2019|261
Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival
|Breast Cancer Research|2013|47
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
|BMC Cancer|2018|41